The diagnosis of CSD in an elderly patient may be especially problematic for several reasons. First, CSD is a disease of the young. The age-specific attack rate is highest among persons aged !10 years and decreases with increasing age [2] [3] [4] . Thus, clinicians caring for elderly patients may be inclined to disregard the possibility of CSD, even in a patient with a typical clinical presentation. Second, although large case studies have included elderly patients (i.e., patients aged 160 years) [5, 6] , little attention has been paid to the specific clinical characteristics of CSD in this age group. Of particular importance, the frequency of atypical manifestations of CSD, which can be associated with considerable morbidity and even mortality, has never been determined in elderly persons. Third, the approach to regional lymphadenopathy in elderly persons differs from that in nonelderly persons, in that malignancy is considered more prominently in the differential diagnosis in elderly persons. The lymphadenopathy associated with CSD is often accompanied by fever and other systemic manifestations, such as fatigue, weight loss, and anorexia [7, 8] , symptoms that might suggest lymphoma or metastatic malignancy [9, 10] .
Failure to consider CSD early in the diagnostic evaluation can lead to unnecessary, expensive, and often invasive testing. To characterize the clinical and laboratory features of CSD in elderly individuals, we analyzed a large cohort of patients in whom the diagnosis of CSD was confirmed at a national reference laboratory.
PATIENTS, MATERIALS, AND METHODS

Patient population.
A surveillance study of CSD was started in Israel in 1991. Clinical specimens obtained from patients suspected by their primary physicians to have CSD were sent to a single laboratory. Patients were enrolled into the study group if they met the CSD case definition (see below). Demographic, epidemfiologic, and clinical data were collected prospectively by means of a structured questionnaire sent to the referring physician. Missing information was obtained by contacting the referring physician, the patient, or the patient's family. In relevant cases, medical records of hospitalized patients were reviewed, and reports of histopathologic, cytologic, and microbiologic examinations were obtained.
A case of CSD was defined as a compatible clinical syndrome and at least 1 positive result of the following confirmatory tests (in the absence of another diagnosis): PCR, EIA for anti-B. henselae antibodies (IgM and/or IgG), or culture for B. henselae. On the basis of this definition, 920 patients were found to have CSD during the period of January 1991-December 2002, of whom 74 patients (8%) were excluded from the study, because data regarding age were not reported. The study group included 846 patients who were divided into patients aged у60 years (elderly group) and patients aged !60 years (nonelderly group). Clinical features and results of laboratory testing for these 2 groups were compared.
CSD was designated as "typical" when regional lymphadenopathy was present without ocular, cutaneous, or visceral involvement. "Atypical" CSD was defined as the presence of у1 of the following syndromes, with or without lymphadenopathy: Parinaud oculoglandular syndrome, posterior segment ocular disease (including neuroretinitis), encephalitis, endocarditis, fever of unknown origin (FUO), erythema nodosum or other skin rashes, hepatitis, splenitis, and osteomyelitis.
Laboratory tests. EIA for detection of anti-B. henselae IgM and IgG antibodies was performed and interpreted as reported elsewhere [7, 11] . Antigen for the EIA was prepared as sarcosylinsoluble outer-membrane protein extracts of the agar-derived B. henselae 87-66 strain (ATCC 49793). The performance of this assay has been previously examined in 84 patients with CSD confirmed by PCR who belonged to the same patient population studied here and in healthy control patients. EIA was 98%-99% specific for B. henselae infection [11] . Cultures for B. henselae on agar plates were performed as described elsewhere [11] . PCR for the detection of B. henselae DNA was performed on lymph node tissue specimens, pus aspirates, heart valve tissue specimens, or material extracted from primary inoculation lesions, as reported elsewhere [12] [13] [14] . Both culture and PCR allowed for speciation of Bartonella species.
Statistical analysis. Comparisons between the elderly and nonelderly CSD groups were performed using the x 2 or Fisher's exact tests for categorical parameters and Student's t test for independent samples for continuous parameters. A multivariate logistic regression model was applied to the data to differentiate between the 2 CSD patient groups on the basis of demographic, clinical, and laboratory variables. This model enabled us to simultaneously study the independent relationship between each parameter and the dichotomous age classification.
Variables that were found in the univariate analysis to be associated with age classification with were considered P ! .2 as candidates for inclusion in the multivariate models. Several model-building methods were used to construct the multivariate model: forward likelihood ratio selection, backward elimination, and all variables in the model. In each step, colinearity between parameters included in the model was assessed by correlation coefficients and x 2 tests. In addition, we explored several potential interactions between different parameters to test for effect modification.
Goodness-of-fit of the models was assessed using HosmerLemeshow tests and the estimated area under the receiveroperator characteristics (ROC) curve. The additive effect of the parameters entered was examined separately by the change in the model fitting statistics, at each step.
was considered to be statistically significant. Statis-P р .05 tical analysis was performed using SPSS software for Windows, version 11.0 (SPSS).
RESULTS
The study group comprised 846 patients with confirmed CSD, of whom 721 (85%) had typical CSD and 125 (15%) had atypical disease. None were known to be immunocompromised. The median age was 18 years (range, 1-89 years). Fiftytwo patients (6%) were aged у60 years and constituted the elderly group (table 1 and figure 1). The median age was 65 years for the elderly group and 16 years for the nonelderly group.
The sex distribution was reversed in patients aged у60 years, compared with nonelderly patients; the ratio of male to female patients was 1:1.4 in the elderly group, compared with 1.4:1 in the nonelderly group ( ). Cat exposure was reported in P p .018 a similar proportion of patients in both age groups (table 1) . Of 45 elderly patients with known cat exposure, 34 (76%) were long-time cat owners, 8 (18%) reported only recently coming into contact with a cat, and 3 (7%) were long-time cat owners but had only recently started feeding stray cats.
The clinical features of CSD in elderly patients differed sig- Three atypical CSD syndromes-FUO, encephalitis, and en- ). The most striking difference, however, was P p .013 in the frequency of B. henselae endocarditis, which was diagnosed in 7 (13.5%) of 52 elderly patients, compared with 2 (0.3%) of 794 nonelderly patients (OR, 61.6; ) (table P ! .001 1). All 9 patients with B. henselae endocarditis fulfilled the modified Duke criteria for definite infective endocarditis [15] . A vegetation was detected by echocardiography in all cases. Seven patients had preexisting valvular disease: a prosthetic valve in 3 patients and native valve abnormality in 4 patients. In all cases, anti-B. henselae IgG was detected by EIA (titer, у1:800 in 7 patients), and results of blood cultures and phase I serologic testing for Q fever were negative. None of the patients was homeless, alcoholic, or infected with body lice. Three patients required valve surgery, and, for all 3 patients, results of PCR performed on specimens of resected valve tissue were positive for B. henselae DNA. Symptoms were present for a median duration of 14 weeks (range, 1-52 weeks) prior to diagnosis. One patient died: a 71-year-old man who was evaluated for malaise, weight loss, and splenomegaly. Notable findings included evidence of splenic and renal infarcts revealed by CT scanning and nephrotic range proteinuria, depressed complement levels, and a positive rheumatoid factor. The patient was afebrile throughout the duration of his illness, and results of blood cultures were negative. An echocardiogram was obtained late in the course of disease and showed a calcified aortic valve vegetation that was believed to be marantic. The patient was discharged without receiving antibiotic therapy and died at a nursing home; B. henselae IgG titer was 1:1600.
Because B. henselae endocarditis was confirmed by PCR in only 3 of 9 patients and serologic testing cannot reliably differentiate between Bartonella quintana and B. henselae [16] , the possibility of B. quintana infection in the remaining 6 patients should be considered. To examine the robustness of our results, we repeated the analysis of our data using different case definitions for B. henselae endocarditis. If only cases with a history of cat exposure are examined, 7 patients should be included in the analysis (5 elderly patients [10.6%] and 2 nonelderly patients [0.3%]). Endocarditis remained strongly associated with age у60 years according to both univariate analysis (OR, 42.1;
) and multivariate analysis (OR, 36.3; ). P ! .001 P ! .001 If only PCR-confirmed cases are analyzed, 3 patients should be included in the analysis, all of whom are elderly (5.8% of the elderly group). In this analysis, endocarditis was still strongly associated with age у60 years according to univariate analysis ( ), but endocarditis cannot be included in the P ! .001 multivariate model because of the absence of cases in the nonelderly group.
The diagnosis of CSD was confirmed by EIA for 801 (94.6%) of 846 patients, by PCR for 150 patients (17.7%), and by B. henselae culture for 3 patients. These proportions were similar for the elderly and nonelderly groups. However, results of EIA for IgM were less often positive for elderly patients than they were for nonelderly patients (30.8 % vs. 46.5%; OR, 0.5;
), whereas results of EIA for IgG were more often pos-P p .03 itive for elderly patients than they were for nonelderly patients (94.2% vs. 79.1%; OR, 4.3;
). The proportion of pa-P p .008 tients who received diagnoses 16 weeks after the onset of symptoms was twofold greater in the elderly group than in the nonelderly group (29.5% vs. 13.3%;
), suggesting a P p .003 significant delay in the diagnosis of CSD in elderly patients. Elderly patients were less likely than nonelderly patients to be treated with antibiotics for their illness (table 1) .
The final multivariate logistic model for the dichotomous age classification included the following characteristics: sex, a diagnosis of endocarditis, FUO, and IgM serostatus (table 2) . Adjustment to these parameters revealed that age у60 years was independently and significantly associated with female sex (OR, 2.4; ), endocarditis (OR, 50.5; ), FUO (OR, P p .01 P ! .001 9.0; ), and negative test results for IgM antibodies (OR, P p .001 0.5; ). The model's overall goodness-of-fit was 0.74, as P p .03 evaluated by the estimated area under the receiver-operator characteristics curve, and 6.22, as evaluated by the HosmerLemeshow x 2 test ( ). Both evaluations indicate an ad-P p .29 equate fit.
DISCUSSION
Because the clinical manifestations of CSD are nonspecific, a correct and timely diagnosis is dependent on the clinician's index of suspicion. Early consideration of CSD as a possible diagnosis, often prompted by a history of cat exposure, leads to specific testing for B. henselae, sparing the patient an extensive diagnostic evaluation. Our findings concur with those of other studies that have shown that most cases of CSD occur in children and young adults [2] [3] [4] . However, as a result of our ongoing CSD surveillance study and the resulting large database created over 11 years, a small but significant number of patients with CSD aged у60 years were identified and characterized. The features of CSD in this age group are distinct from those of younger patients and should, therefore, be highlighted.
Atypical CSD appears to be more common in elderly patients than in nonelderly patients. In our study, 1 in 4 patients with CSD aged у60 years had atypical disease, and a similar proportion had no lymphadenopathy, thus lacking the clinical hallmark of CSD. In contrast, only 12% of nonelderly patients had an atypical disease, and 6% had no lymphadenopathy. Therefore, the diagnosis of CSD in elderly patients presents a special challenge. FUO, reported in nearly 8% of elderly patients, was significantly more common in this age group than in nonelderly patients. B. henselae was previously reported as a cause of FUO in 7 (4.8%) of 146 children [17, 18] . In another study of 41 patients with serologic test results positive for B. henselae, 13 of 14 patients with prolonged fever were !20 years of age [18] . It is unclear, however, whether this study included elderly patients. Our data indicate that B. henselae infection should be considered in the differential diagnosis of FUO in elderly patients, especially if a history of cat exposure is elicited.
Of particular importance is the disproportionate occurrence of the most severe manifestation of CSD, endocarditis, in elderly patients. In contrast with typical CSD, which is a self-limited disease, endocarditis requires specific antibiotic treatment and often requires surgical excision of the involved valve [19] [20] [21] . In our study, the OR was 61.6 for endocarditis in a patient у60 years old, 3 of 7 elderly patients with this diagnosis underwent valve surgery, and another patient died. The age of previously reported patients with Bartonella endocarditis is significantly younger than that of patients in our cohort [20, 21] . However, those studies included both patients with B. henselae and B. quintana infection, 2 groups with markedly different demographic characteristics.
It has been previously noted that Bartonella endocarditis is associated with a particularly high mortality rate and frequent valve destruction requiring valve replacement, because of delayed diagnosis [20, 21] . In our study, elderly patients with endocarditis were symptomatic for a median of 14 weeks before receiving a diagnosis. The impact of delayed diagnosis is exemplified by the patient who died of Bartonella endocarditis after a protracted illness that was believed by his physicians to be a noninfectious inflammatory process.
Our data suggest that the diagnosis of CSD is delayed in patients aged у60 years, compared with nonelderly patients. A higher proportion of elderly patients had prolonged duration (i.e., a duration of 16 weeks) of symptoms prior to receiving a diagnosis of CSD. The higher proportion of elderly patients with positive test results for IgG and the lower proportion of elderly patients with positive test results for IgM also suggest that CSD was often diagnosed at a later stage in these patients. Anti-B. henselae IgM titers rapidly decrease after the onset of illness; therefore, IgM is a reliable marker for acute infection [7] . Elderly patients were less likely to receive antibiotic treatment than were nonelderly patients, indicating that an infectious disease was less frequently considered for elderly patients. The delay in diagnosis may result from the higher proportion of elderly patients with atypical disease and the greater emphasis placed by physicians on malignant etiologies when evaluating an elderly patient with regional lymphadenopathy.
Reinfection with B. henselae after CSD has not been de-scribed, implying that lifelong immunity is induced. Because most patients with CSD are cat lovers with a long history of exposure to cats, the occurrence of CSD in elderly patients seems somewhat unexpected. It should be noted, however, that B. henselae is transmitted inefficiently from cats to humans, as is apparent from the absence of outbreaks within households and from the lack of evidence of higher than normal rates of infection among veterinarians [22] . In addition, CSD in an elderly patient may be caused by either a new exposure to a cat by a person who generally avoids them or by a change in an existing pattern of cat exposure to a pattern with a higher risk of B. henselae infection. Eleven (25%) of the 45 elderly patients with cat exposure reported either new, incidental cat exposure or new exposure to a stray cat. The clinical manifestations of B. henselae infection are determined by the host's immune response; localized disease (e.g., regional lymphadenopathy) appears in patients with an intact immune system, whereas systemic infection appears in immunocompromised patients [23] . The influence of age on the clinical characteristics of CSD can be similarly explained. In nonelderly patients, a vigorous immune response causes regional lymphadenopathy, thus limiting the spread of infection. In elderly patients, waning immunity may result in bacteremia and systemic infection, including endocarditis, in the absence of lymphadenopathy.
Patients were enrolled into the present study through physician referral, thus introducing possible referral bias. Because clinicians are generally less suspicious of possible CSD in elderly patients, such a bias may cause underestimation of the true number of elderly patients with CSD and overrepresentation of elderly patients with severe manifestations of CSD.
We conclude that CSD, although typically a disease of children and young adults, should be considered when evaluating an elderly patient with a compatible clinical syndrome. Familiarity with the characteristics of CSD in this age group should aid clinicians caring for elderly patients. In particular, the high proportion of elderly patients with CSD manifesting as endocarditis or FUO requires that clinicians inquire about cat exposure and perform serologic testing for B. henselae early when faced with these syndromes.
